{"ticker": {"uuid": "65f88221-14dc-4a11-8ddc-81fbb9b05a84", "symbol": "IPN", "name": "Ipsen S.A.", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Weekly Recap: Dysport Phase III migraine success and Ipsen Natixis holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPcExPd3RTeU5HUXJVQ283eExpbUtBX05iODVNY3hQXy1fdnVPM3Nsci1ROERSWjI0d01odzhHV21YSzBQczhZeDg5N3NxODFvN3RUZ19GY3FsRnl2V2piWGxjZG5zeFpJTy1UQzlsTUN0YmpsbFltdHpqWkViRDczVTFtaC1nQlRtU0Jyc01vVFgyZXRxelI5aTh1UEZiNUVWdm5xblZPWk5DbXpsakZzejR2WWx0MVc4SFNhREV5LXUydXEyeHBsQ1F3dnVuV0NCdVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T05:14:00+00:00", "published_display": "13 Jul 2026 05:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Ipsen S.A. Just Paid \u20ac700M For Memo Therapeutics AG (OTCMKTS:IPSEY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOWGRjVnZTZDVRam5xRGwyWVVnUDJZTDRhdnMxNFpyX0lxM1R5OGlfN1dyOXB4UktwbGNqbE1DZ1VOZVhTRUlyS1ZGYTBKX2tROE5SLWVoX0tPbzJta2tqbzR6N1B2SlliYkxKSGxiWDBsVjBaM0hsVUdWNTlGeHVxYWk2bkJjRzY1bzJDUlR2V29VcTlqYTk4Wl96RWx6dGpX?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T12:40:00+00:00", "published_display": "10 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQZGpVVjRLQldGSWRfaS10eWx4UUVwaktlbXg1Y0piUHc1OTdoRHdkU29VdXlRZXNIcF9XX3RDOWtPQi1LbWpIcW9ObXhMUGRJbm5ISkd4a3VsajVRQXMwWWMzNVR2cGZjOFNLd0xpd0ZaSUxDT1JOZXA3ZGVDeDFXX3hic0dpdkpvYkxJcmRSQ2xoS1dwM1FKeA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOemR1NWlRNFh3SmI0MnEyY3ozaGJNNXBrMm4zbnBTWXBLYkxsWlNfd1FnMzFGVEtIY3FHTGdFLVBHaldrbTliN25PSVZKYk1LMkh2dHNOZXBobUJDWWJaM0x4Wm9kc19qNFJ5dndMaEtYQmVPZ2pscnZHZDhBc25vVHYxR1BZaWFEMUJIOW9oajNvUzNUeE1KcHd5NUV0cEtLTjNlRkR6NVhHc3BCc0ZsWFdtNHd3WWlOb0VfLUJnUnJuQkVIUEdEX2tRTHd1ZXZIbmZzcEpB0gHbAUFVX3lxTFBkSVA2YjdvT2RMSExqdENocGtLVHpUMlB0UDRBSUhzVGJGakkwZ0syaUVPNFJKVXhobUE0Y01UbjdQVmRCcjc1Y1BVOWtzbVFXeTlaNDVDeXRHbGE0UjE1ZU83YV9CYTBndmxhZVpkLWM0UmRCdTJqa0MxaC1rSktvNnVpSk4xazNRdnN1OFdwQnh6dHhJZUZlZWRXNVJyT25QU3hsNHBSd0VsQmFrVkZVUnhLRjhxa3Y0REdpcG5iLWFiUzdiQ29iZWMzaGRlVmt2VEJSdUJkTGs5OA?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T14:01:49+00:00", "published_display": "06 Jul 2026 14:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Stock Looks Reasonable On Cash Flow Yet Rich On Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T05:17:27+00:00", "published_display": "05 Jul 2026 05:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen SA Actuals & Estimates (EURONEXT:IPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTTFZNUZ6SzlIZ2RYRGN6RlpuOFZHUkZMLUV3dFMtQk1xekl1bU9QVk5SU2x4dnlGNUpMa1ROMVZKMS1qZjFHV3JTaVhLaVJpSDFneVlqeUJLemRYckwwRi1MLTNKRGhXcmZaR1BUN3BTVnVXSU9XUGUxMEJyWjVQWDZxNTdaR2s?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T16:32:33+00:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After A Strong Year-To-Date Rise And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMFFiajVtUHNKcFBBZVFUSlQtalEzOEc2a2k2MVVjZ3RubWJicEhVTGlkeUIwMkZpR1RVbHVYZy10dG54MF9KcTY5LWxFSWRoeGZEOHlTS1FmQkZwVXM2TmpabW9VMjJZSFBYbjVvYVp1b0ItMGxlU01UVHp5ai1hWTFIS2UxTGxtMHB1ZEFuVkItellNUllWY01nYlBDZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen announces the launch of an Employee Shareholding Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZEc0QmVCdlBpNVJSeUE0S1J2ZkFSR1J2b0hpTm43N2FNbGdjQ1JyM0dQckRfMTc5M21Hb0gwSlZSUFlyRUJHNGdrWnJCbTVTVGlFYmJEa0w1dGxRVlk4YVQ1SWk5b0RTTU04Q2ZNa0ZDeVVmdURIRkNWUkJ2a1NyeTR2M1BDaVdaVmZHZy1qSFNQWGpsUFozMDUtZkZ5b2Y0SklKTUc1S1JRdzRDVlE?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen stock falls as Galderma feud clouds strong corabotase data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQaFZaMlVfcU1TTW9VVnhfZnBKWlNfajNCaGpsTE02Q0hHeHp3aWRyZFFHRVVwdkx3LTE3MExCNU1iaFVkcE1IZGdrcnJ5V2ZzTDZ1X3I4R2VrR19CQzJkVGYwdFgzSE1yejVXWjJkOGtJMWJmVmRnY1Y3QzF5Z1J0ZGtIcTZ0UGlSakU5YTJxeHQybzJOS010dGZYYjZUYmIyenR4S1VBTG1jdW1rYldEalpkWWhnM1BFbmdCcUdB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After Strong Recent Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcjBlaktzS0dQX3Y4Z3lEdVpWRlJHV1RXb2VudDBRWHNmRm90NVBjMzdzUFQ3NVZ2TEZHVGxOV0ozak1va0IySS1BNFktTjBNQVZncnpZSUFJcGxGV29HX25OUDNhUzdZRk43U1FEUERVNUhzZGNCdW5uemRqRTF2ZHBFWDhpOHFUN1I5Q0JSNHQtSFZBY0l4djFGMTFxZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:IPSEY) 2026-04-23", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPbE1mSmNsQTBWMEtVc1dIbXAzTDlVWGhoR0ZfcS0wY1FlWDd4VDV1NFVLUG5mTUt3TWZtbkVIMDNDTEVqWENncVFBRnp3bzgtLU9aSl9EU010WVU3OHl4cW5ZTGtjWGwtZjlHaVlmbG9saFRnZ3BmNW41bl9jaWhMUENua0JIZTJGeG5WRUNCWkIwcmkyR0F2MA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Ipsen (ENXTPA:IPN) After Its 65% One-Year Share Price Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNREt1dlNJOGRxZEN2a0Z6UU16OWQwRmIycTJrSUZMakhSZTcxYjk5WHJrZEdmWk9yeFpSZ1J4cnZ4WUxyOWd5T3BBQ2F6SlBNR1Q4SHBqdjRXMG1JNWFxYzVFeWpWV2NBZ2c3NVJEQ1puUXFsdGhQVi0xNzJSTW8wVGpOTGhmMTNtZEMxNFAtTl9ucEtId3d1cGdHSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen S.A. 2025 Q3 - Results - Earnings Call Presentation (OTCMKTS:IPSEY) 2025-10-22", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORHpLbEVXTjl5eHpDZFc3N2RPZUtkTGtmeFd5RFdCZzRiYXIwY0FZQlBBdTJhU3RmQ29mOElabGU0TWNjaHZRSHhlMlRicnNiOUc1cTQ2R0JWNldaNXhHeEZCT0tYeHpBbUZIZG04bkJDSE5xbWxpVW00LTZnc0lDR0xlN0RuQVhZOTY2Uk5aMXlMaW1MaXdVYg?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen\u2019s IPN10200 Demonstrates Long-Lasting Efficacy in Phase II LANTIC Trial for Glabellar Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNZTlzV2ZaYzRUYnBMMVpoY3NwNjFFMC1vQm8xSFlSUlh5YThqVUVSUmRMdWZuLXVyM05pWlJLR2JIYnZBeWVNdlg0dWVySDVKUkZaODFhQnkyR042QkxpZmc5WkxVUlJZRFFXSlcwVGl5OFcxZzhzOEo3LTN4a0psWWRnazJsWlVtWjZERDRRb3h2VWpLWmx2RDdQX1k1bE42cVVnZTYzN3RJdTBncmZzMWpwa2k?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Employee of French drugmaker Ipsen to plead guilty to US insider trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPck9NTElVdmhWaURzVzlXTzNGakpPZkNDTV9pZ1VzOUF1anVEbmtybGdWRHZhSTBqV3AwMmZZN1ctOW5BeGFnalhtYkZ2eFoxd0RsMloyaVROaHFjRThCR0ljdDl1aUEtQkowTlJpTHV2R1pLYTZqNjFjZnZWRFlPSURiWWFKWE45TmxtSjVkZkdHUGw5a3M0ZVB5QnM4ZkZxR2FFekhFQU55b3FHa1ljNnU3RkxhT2FYRUlKUFlQbFBiUmVxSGJ1NVh0azZhcGpH?oc=5", "source_name": "Reuters", "published_at": "2024-09-10T07:00:00+00:00", "published_display": "10 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen Earnings: Dysport & Cabometyx Drive Growth as Pipeline Develops; Shares Slightly Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTzZZN0hVNzRWOGpCWnB0bWd5V2FreFRzUU9nc1ZMZlU4amRBQngtLXdLaVdBclNoZnZxRGNpaFpWZl9neDZvUnNGYjY1VHdMX045R2lSMW5kNjlVS1ZWcTlQRWJmYkNOY01wSURfRU56aHFKTDVobjMtSllwLTNsRGwtM0JvSEVlMkowV2ZmYUVxZ1dTdFVIbWs1RDFyQUEzWGF6NUZzbXF5NjRfaFlpaG9TekZNNllXdVdYR0hZQ3cydGY5?oc=5", "source_name": "Morningstar", "published_at": "2023-10-30T07:00:00+00:00", "published_display": "30 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Weekly Recap: Dysport Phase III migraine success and Ipsen Natixis holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPcExPd3RTeU5HUXJVQ283eExpbUtBX05iODVNY3hQXy1fdnVPM3Nsci1ROERSWjI0d01odzhHV21YSzBQczhZeDg5N3NxODFvN3RUZ19GY3FsRnl2V2piWGxjZG5zeFpJTy1UQzlsTUN0YmpsbFltdHpqWkViRDczVTFtaC1nQlRtU0Jyc01vVFgyZXRxelI5aTh1UEZiNUVWdm5xblZPWk5DbXpsakZzejR2WWx0MVc4SFNhREV5LXUydXEyeHBsQ1F3dnVuV0NCdVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T05:14:00+00:00", "published_display": "13 Jul 2026 05:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Ipsen S.A. Just Paid \u20ac700M For Memo Therapeutics AG (OTCMKTS:IPSEY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOWGRjVnZTZDVRam5xRGwyWVVnUDJZTDRhdnMxNFpyX0lxM1R5OGlfN1dyOXB4UktwbGNqbE1DZ1VOZVhTRUlyS1ZGYTBKX2tROE5SLWVoX0tPbzJta2tqbzR6N1B2SlliYkxKSGxiWDBsVjBaM0hsVUdWNTlGeHVxYWk2bkJjRzY1bzJDUlR2V29VcTlqYTk4Wl96RWx6dGpX?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T12:40:00+00:00", "published_display": "10 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQZGpVVjRLQldGSWRfaS10eWx4UUVwaktlbXg1Y0piUHc1OTdoRHdkU29VdXlRZXNIcF9XX3RDOWtPQi1LbWpIcW9ObXhMUGRJbm5ISkd4a3VsajVRQXMwWWMzNVR2cGZjOFNLd0xpd0ZaSUxDT1JOZXA3ZGVDeDFXX3hic0dpdkpvYkxJcmRSQ2xoS1dwM1FKeA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T14:01:49+00:00", "published_display": "06 Jul 2026 14:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Stock Looks Reasonable On Cash Flow Yet Rich On Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T05:17:27+00:00", "published_display": "05 Jul 2026 05:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen SA Actuals & Estimates (EURONEXT:IPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTTFZNUZ6SzlIZ2RYRGN6RlpuOFZHUkZMLUV3dFMtQk1xekl1bU9QVk5SU2x4dnlGNUpMa1ROMVZKMS1qZjFHV3JTaVhLaVJpSDFneVlqeUJLemRYckwwRi1MLTNKRGhXcmZaR1BUN3BTVnVXSU9XUGUxMEJyWjVQWDZxNTdaR2s?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T16:32:33+00:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After A Strong Year-To-Date Rise And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMFFiajVtUHNKcFBBZVFUSlQtalEzOEc2a2k2MVVjZ3RubWJicEhVTGlkeUIwMkZpR1RVbHVYZy10dG54MF9KcTY5LWxFSWRoeGZEOHlTS1FmQkZwVXM2TmpabW9VMjJZSFBYbjVvYVp1b0ItMGxlU01UVHp5ai1hWTFIS2UxTGxtMHB1ZEFuVkItellNUllWY01nYlBDZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen announces the launch of an Employee Shareholding Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZEc0QmVCdlBpNVJSeUE0S1J2ZkFSR1J2b0hpTm43N2FNbGdjQ1JyM0dQckRfMTc5M21Hb0gwSlZSUFlyRUJHNGdrWnJCbTVTVGlFYmJEa0w1dGxRVlk4YVQ1SWk5b0RTTU04Q2ZNa0ZDeVVmdURIRkNWUkJ2a1NyeTR2M1BDaVdaVmZHZy1qSFNQWGpsUFozMDUtZkZ5b2Y0SklKTUc1S1JRdzRDVlE?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen stock falls as Galderma feud clouds strong corabotase data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQaFZaMlVfcU1TTW9VVnhfZnBKWlNfajNCaGpsTE02Q0hHeHp3aWRyZFFHRVVwdkx3LTE3MExCNU1iaFVkcE1IZGdrcnJ5V2ZzTDZ1X3I4R2VrR19CQzJkVGYwdFgzSE1yejVXWjJkOGtJMWJmVmRnY1Y3QzF5Z1J0ZGtIcTZ0UGlSakU5YTJxeHQybzJOS010dGZYYjZUYmIyenR4S1VBTG1jdW1rYldEalpkWWhnM1BFbmdCcUdB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After Strong Recent Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcjBlaktzS0dQX3Y4Z3lEdVpWRlJHV1RXb2VudDBRWHNmRm90NVBjMzdzUFQ3NVZ2TEZHVGxOV0ozak1va0IySS1BNFktTjBNQVZncnpZSUFJcGxGV29HX25OUDNhUzdZRk43U1FEUERVNUhzZGNCdW5uemRqRTF2ZHBFWDhpOHFUN1I5Q0JSNHQtSFZBY0l4djFGMTFxZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:IPSEY) 2026-04-23", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPbE1mSmNsQTBWMEtVc1dIbXAzTDlVWGhoR0ZfcS0wY1FlWDd4VDV1NFVLUG5mTUt3TWZtbkVIMDNDTEVqWENncVFBRnp3bzgtLU9aSl9EU010WVU3OHl4cW5ZTGtjWGwtZjlHaVlmbG9saFRnZ3BmNW41bl9jaWhMUENua0JIZTJGeG5WRUNCWkIwcmkyR0F2MA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Ipsen (ENXTPA:IPN) After Its 65% One-Year Share Price Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNREt1dlNJOGRxZEN2a0Z6UU16OWQwRmIycTJrSUZMakhSZTcxYjk5WHJrZEdmWk9yeFpSZ1J4cnZ4WUxyOWd5T3BBQ2F6SlBNR1Q4SHBqdjRXMG1JNWFxYzVFeWpWV2NBZ2c3NVJEQ1puUXFsdGhQVi0xNzJSTW8wVGpOTGhmMTNtZEMxNFAtTl9ucEtId3d1cGdHSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen S.A. 2025 Q3 - Results - Earnings Call Presentation (OTCMKTS:IPSEY) 2025-10-22", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORHpLbEVXTjl5eHpDZFc3N2RPZUtkTGtmeFd5RFdCZzRiYXIwY0FZQlBBdTJhU3RmQ29mOElabGU0TWNjaHZRSHhlMlRicnNiOUc1cTQ2R0JWNldaNXhHeEZCT0tYeHpBbUZIZG04bkJDSE5xbWxpVW00LTZnc0lDR0xlN0RuQVhZOTY2Uk5aMXlMaW1MaXdVYg?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen\u2019s IPN10200 Demonstrates Long-Lasting Efficacy in Phase II LANTIC Trial for Glabellar Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNZTlzV2ZaYzRUYnBMMVpoY3NwNjFFMC1vQm8xSFlSUlh5YThqVUVSUmRMdWZuLXVyM05pWlJLR2JIYnZBeWVNdlg0dWVySDVKUkZaODFhQnkyR042QkxpZmc5WkxVUlJZRFFXSlcwVGl5OFcxZzhzOEo3LTN4a0psWWRnazJsWlVtWjZERDRRb3h2VWpLWmx2RDdQX1k1bE42cVVnZTYzN3RJdTBncmZzMWpwa2k?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Employee of French drugmaker Ipsen to plead guilty to US insider trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPck9NTElVdmhWaURzVzlXTzNGakpPZkNDTV9pZ1VzOUF1anVEbmtybGdWRHZhSTBqV3AwMmZZN1ctOW5BeGFnalhtYkZ2eFoxd0RsMloyaVROaHFjRThCR0ljdDl1aUEtQkowTlJpTHV2R1pLYTZqNjFjZnZWRFlPSURiWWFKWE45TmxtSjVkZkdHUGw5a3M0ZVB5QnM4ZkZxR2FFekhFQU55b3FHa1ljNnU3RkxhT2FYRUlKUFlQbFBiUmVxSGJ1NVh0azZhcGpH?oc=5", "source_name": "Reuters", "published_at": "2024-09-10T07:00:00+00:00", "published_display": "10 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen Earnings: Dysport & Cabometyx Drive Growth as Pipeline Develops; Shares Slightly Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTzZZN0hVNzRWOGpCWnB0bWd5V2FreFRzUU9nc1ZMZlU4amRBQngtLXdLaVdBclNoZnZxRGNpaFpWZl9neDZvUnNGYjY1VHdMX045R2lSMW5kNjlVS1ZWcTlQRWJmYkNOY01wSURfRU56aHFKTDVobjMtSllwLTNsRGwtM0JvSEVlMkowV2ZmYUVxZ1dTdFVIbWs1RDFyQUEzWGF6NUZzbXF5NjRfaFlpaG9TekZNNllXdVdYR0hZQ3cydGY5?oc=5", "source_name": "Morningstar", "published_at": "2023-10-30T07:00:00+00:00", "published_display": "30 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 16, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 11, "score": 53, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 6.75, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 3.8, "count": 5}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 162.7, "latest_week": "2026-07-10", "one_week_move": -4.7, "four_week_move": 3.1, "twelve_week_move": 1.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.297065, "market_dynamics_buy_signal": false, "relative_strength": 15.1191, "fair_value_gap": 37.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.8242, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.7% over one week, +3.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 5}, {"label": "Seeking Alpha", "count": 3}, {"label": "TradingView", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Investing.com", "count": 1}, {"label": "Applied Clinical Trials Online", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Morningstar", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.7% over one week, +3.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Weekly Recap: Dysport Phase III migraine success and Ipsen Natixis holdings"}], "updated_at": "2026-07-17T06:17:51.370426+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}